Strategies targeting angiogenesis in advanced non-small cell lung cancer

Tumor angiogenesis is a frequent event in the development and progression of non-small cell lung cancer (NSCLC) and has been identified as a promising therapeutic target. The vascular endothelial growth factor (VEGF) family and other angiogenic factors, including fibroblast growth factor and platele...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Chen, Jianpeng, Guo, Yan, Wang, Baocheng, Chu, Huili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581155/
https://www.ncbi.nlm.nih.gov/pubmed/28881856
http://dx.doi.org/10.18632/oncotarget.17957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581155/
https://www.ncbi.nlm.nih.gov/pubmed/28881856
http://dx.doi.org/10.18632/oncotarget.17957

Ejemplares similares